N-Gene

Biotechnology, Pharmaceutical
Founded in 1997-01-01
Szentistván, Borsod-Abauj-Zemplen, Hungary
For Profit

About N-Gene

N-Gene is a developer of clinical-stage bio-pharmaceutical drugs designed to focus on the discovery, development, and commercialization of proprietary synthetic small molecules. The company's drugs use proprietary synthetic small molecule BGP-15 that has been found efficacious in various indications relating to adverse metabolic conditions, including type 2 diabetes mellitus by blocking JNK phosphorylation and has a new therapeutic effect via stress response modulation, enabling pharmaceutical companies to get a series of synthetic molecules to treat the insulin-resistance syndrome, improve cancer chemotherapy, and slow skin aging.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 3000000 USD
  • Last Funding: None (Private Equity)
  • Funding Status: Private Equity

Technology Stack

N-Gene actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Pharmaceutical

Headquarters: Szentistván, Borsod-Abauj-Zemplen, Hungary